These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 28835636

  • 1. Potential inhibitors designed against NDM-1 type metallo-β-lactamases: an attempt to enhance efficacies of antibiotics against multi-drug-resistant bacteria.
    Khan AU, Ali A, Danishuddin, Srivastava G, Sharma A.
    Sci Rep; 2017 Aug 23; 7(1):9207. PubMed ID: 28835636
    [Abstract] [Full Text] [Related]

  • 2. Designing of inhibitors against CTX-M-15 type β-lactamase: potential drug candidate against β-lactamases-producing multi-drug-resistant bacteria.
    Ali A, Danishuddin, Maryam L, Srivastava G, Sharma A, Khan AU.
    J Biomol Struct Dyn; 2018 May 23; 36(7):1806-1821. PubMed ID: 28545327
    [Abstract] [Full Text] [Related]

  • 3. High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1.
    Rehman MT, AlAjmi MF, Hussain A, Rather GM, Khan MA.
    Int J Mol Sci; 2019 Feb 14; 20(4):. PubMed ID: 30769822
    [Abstract] [Full Text] [Related]

  • 4. Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization.
    Farhat N, Gupta D, Ali A, Kumar Y, Akhtar F, Kulanthaivel S, Mishra P, Khan F, Khan AU.
    Microbiol Spectr; 2022 Oct 26; 10(5):e0045022. PubMed ID: 36069578
    [Abstract] [Full Text] [Related]

  • 5. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach.
    Muteeb G, Alsultan A, Farhan M, Aatif M.
    Molecules; 2022 Feb 14; 27(4):. PubMed ID: 35209073
    [Abstract] [Full Text] [Related]

  • 6. Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design.
    Linciano P, Cendron L, Gianquinto E, Spyrakis F, Tondi D.
    ACS Infect Dis; 2019 Jan 11; 5(1):9-34. PubMed ID: 30421910
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis, and in vitro and biological evaluation of potent amino acid-derived thiol inhibitors of the metallo-β-lactamase IMP-1.
    Arjomandi OK, Hussein WM, Vella P, Yusof Y, Sidjabat HE, Schenk G, McGeary RP.
    Eur J Med Chem; 2016 May 23; 114():318-27. PubMed ID: 27017264
    [Abstract] [Full Text] [Related]

  • 8. Fragment-based discovery of inhibitor scaffolds targeting the metallo-β-lactamases NDM-1 and VIM-2.
    Christopeit T, Leiros HK.
    Bioorg Med Chem Lett; 2016 Apr 15; 26(8):1973-7. PubMed ID: 26976213
    [Abstract] [Full Text] [Related]

  • 9. Targeting clinically-relevant metallo-β-lactamases: from high-throughput docking to broad-spectrum inhibitors.
    Brindisi M, Brogi S, Giovani S, Gemma S, Lamponi S, De Luca F, Novellino E, Campiani G, Docquier JD, Butini S.
    J Enzyme Inhib Med Chem; 2016 Apr 15; 31(sup1):98-109. PubMed ID: 27121013
    [Abstract] [Full Text] [Related]

  • 10. Efforts towards the inhibitor design for New Delhi metallo-beta-lactamase (NDM-1).
    Nagulapalli Venkata KC, Ellebrecht M, Tripathi SK.
    Eur J Med Chem; 2021 Dec 05; 225():113747. PubMed ID: 34391033
    [Abstract] [Full Text] [Related]

  • 11. Structure-guided optimization of D-captopril for discovery of potent NDM-1 inhibitors.
    Ma G, Wang S, Wu K, Zhang W, Ahmad A, Hao Q, Lei X, Zhang H.
    Bioorg Med Chem; 2021 Jan 01; 29():115902. PubMed ID: 33302045
    [Abstract] [Full Text] [Related]

  • 12. Progress toward inhibitors of metallo-β-lactamases.
    McGeary RP, Tan DT, Schenk G.
    Future Med Chem; 2017 May 01; 9(7):673-691. PubMed ID: 28504895
    [Abstract] [Full Text] [Related]

  • 13. Recent research and development of NDM-1 inhibitors.
    Wang T, Xu K, Zhao L, Tong R, Xiong L, Shi J.
    Eur J Med Chem; 2021 Nov 05; 223():113667. PubMed ID: 34225181
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and biological evaluation of Aspergillomarasmine A derivatives as novel NDM-1 inhibitor to overcome antibiotics resistance.
    Zhang J, Wang S, Wei Q, Guo Q, Bai Y, Yang S, Song F, Zhang L, Lei X.
    Bioorg Med Chem; 2017 Oct 01; 25(19):5133-5141. PubMed ID: 28784300
    [Abstract] [Full Text] [Related]

  • 15. Novel metallo-β-lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo-lactamase-1 (NDM-1)-harbouring bacteria.
    Guo Y, Liu H, Yang M, Ding R, Gao Y, Niu X, Deng X, Wang J, Feng H, Qiu J.
    Br J Pharmacol; 2024 Jan 01; 181(1):54-69. PubMed ID: 37539785
    [Abstract] [Full Text] [Related]

  • 16. Real-Time Monitoring of NDM-1 Activity in Live Bacterial Cells by Isothermal Titration Calorimetry: A New Approach To Measure Inhibition of Antibiotic-Resistant Bacteria.
    Zhang YJ, Wang WM, Oelschlaeger P, Chen C, Lei JE, Lv M, Yang KW.
    ACS Infect Dis; 2018 Dec 14; 4(12):1671-1678. PubMed ID: 30383355
    [Abstract] [Full Text] [Related]

  • 17. Discovery of potential inhibitors against New Delhi metallo-β-lactamase-1 from natural compounds: in silico-based methods.
    Salari-Jazi A, Mahnam K, Sadeghi P, Damavandi MS, Faghri J.
    Sci Rep; 2021 Jan 27; 11(1):2390. PubMed ID: 33504907
    [Abstract] [Full Text] [Related]

  • 18. Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria.
    Klingler FM, Wichelhaus TA, Frank D, Cuesta-Bernal J, El-Delik J, Müller HF, Sjuts H, Göttig S, Koenigs A, Pos KM, Pogoryelov D, Proschak E.
    J Med Chem; 2015 Apr 23; 58(8):3626-30. PubMed ID: 25815530
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors.
    Schnaars C, Kildahl-Andersen G, Prandina A, Popal R, Radix S, Le Borgne M, Gjøen T, Andresen AMS, Heikal A, Økstad OA, Fröhlich C, Samuelsen Ø, Lauksund S, Jordheim LP, Rongved P, Åstrand OAH.
    ACS Infect Dis; 2018 Sep 14; 4(9):1407-1422. PubMed ID: 30022668
    [Abstract] [Full Text] [Related]

  • 20. In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors.
    Cain R, Brem J, Zollman D, McDonough MA, Johnson RM, Spencer J, Makena A, Abboud MI, Cahill S, Lee SY, McHugh PJ, Schofield CJ, Fishwick CWG.
    J Med Chem; 2018 Feb 08; 61(3):1255-1260. PubMed ID: 29271657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.